This issue of Hematology/Oncology Clinics will focus on Upper Gastrointestinal Malignancies; specifically, articles on the following: Epidemiology / Genetics, H. pylori and the gastric microbiome in gastric cancer carcinogenesis; Barrett’s esophagus and esophageal cancer; Tumor Staging; Localized disease; Metastatic Disease; Immunotherapy Antiangiogenic therapy; and many more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Tumor Biology - p. xiv 9. The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research - p. 389 10. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma - p. 409 11. Management - p. 426 12. Staging in Esophageal and Gastric Cancers - p. 427 13. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? - p. 441 14. The Role of Radiotherapy in Localized Esophageal and Gastric Cancer - p. 453 15. Management of Metastatic Gastric Cancer - p. 469 16. Emerging Targeted Therapies - p. 483 17. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer - p. 485 18. Antiangiogenic Therapy in Gastroesophageal Cancer - p. 499 19. Update on Gastroesophageal Adenocarcinoma Targeted Therapies - p. 511 20. Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma - p. 529 21. Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer - p. 545 22. Index - p. 553
No hay muestra disponible
No hay ficha técnica disponible
This issue of Hematology/Oncology Clinics will focus on Upper Gastrointestinal Malignancies; specifically, articles on the following: Epidemiology / Genetics, H. pylori and the gastric microbiome in gastric cancer carcinogenesis; Barrett’s esophagus and esophageal cancer; Tumor Staging; Localized disease; Metastatic Disease; Immunotherapy Antiangiogenic therapy; and many more!
1. Cover image - p. i 2. Title page - p. i 3. Table of Contents - p. i 4. Copyright - p. ii 5. Contributors - p. iii 6. Forthcoming Issues - p. xi 7. Preface - p. xiii 8. Tumor Biology - p. xiv 9. The Gastric Microbiome and Its Influence on Gastric Carcinogenesis: Current Knowledge and Ongoing Research - p. 389 10. Barrett Esophagus and Intramucosal Esophageal Adenocarcinoma - p. 409 11. Management - p. 426 12. Staging in Esophageal and Gastric Cancers - p. 427 13. Management of Locally Advanced Gastroesophageal Cancer: Still a Multidisciplinary Global Challenge? - p. 441 14. The Role of Radiotherapy in Localized Esophageal and Gastric Cancer - p. 453 15. Management of Metastatic Gastric Cancer - p. 469 16. Emerging Targeted Therapies - p. 483 17. The Evolving Role of Checkpoint Inhibitors in the Management of Gastroesophageal Cancer - p. 485 18. Antiangiogenic Therapy in Gastroesophageal Cancer - p. 499 19. Update on Gastroesophageal Adenocarcinoma Targeted Therapies - p. 511 20. Emerging Novel Therapeutic Agents in the Treatment of Patients with Gastroesophageal and Gastric Adenocarcinoma - p. 529 21. Future Directions in Improving Outcomes for Patients with Gastric and Esophageal Cancer - p. 545 22. Index - p. 553
No hay muestra disponible
No hay ficha técnica disponible
